Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate
- 30 June 1974
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 19 (3) , 407-415
- https://doi.org/10.1016/s0021-9150(74)80005-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical and metabolic effects of pentaerythritol tetranicotinate (perycit®) and a comparison with plain nicotinic acidAtherosclerosis, 1974
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- Studies on Anti-atherosclerotic Agents. II. : Experimental Studies of 1, 3-Propanediol bis (2-p-Chlorophenoxyisobutyrate)(CLY-503) for Anti-atherosclerotic AgentsYAKUGAKU ZASSHI, 1970
- Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatmentJournal of Atherosclerosis Research, 1968
- PENTAERYTHRITOLTETRANICOTINATE (PERYCIT®) IN THE TREATMENT OF HYPERCHOLESTEROLAEMIAActa Medica Scandinavica, 1968
- Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.Published by Elsevier ,1968
- Determination of serum triglyceridesJournal of Atherosclerosis Research, 1963
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955